In the present study, statistical comparison of different Barcelona Stages in patients with HCC revealed that AFP levels were significantly higher in stages A and B (median, 243 and 251 ng/dl, respectively) than in stage 0 (median, 7.9 ng/dl). Here, AFP is linked to hepatocellular carcinoma.